loading
Schlusskurs vom Vortag:
$4.32
Offen:
$4.46
24-Stunden-Volumen:
9,021
Relative Volume:
0.15
Marktkapitalisierung:
$224.40M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+7.40%
1M Leistung:
+66.67%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
Value
$4.00
$4.518
1-Wochen-Bereich:
Value
$3.5237
$4.518
52-Wochen-Spanne:
Value
$2.32
$5.69

Wellgistics Health Inc Stock (WGRX) Company Profile

Name
Firmenname
Wellgistics Health Inc
Name
Telefon
1-843-302-1785
Name
Adresse
3000 BAYPORT DRIVE SUITE 950, TAMPA
Name
Mitarbeiter
0
Name
Twitter
Name
Nächster Verdiensttermin
Name
Neueste SEC-Einreichungen
Name
WGRX's Discussions on Twitter

Vergleichen Sie WGRX mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Pharmaceutical Retailers icon
WGRX
Wellgistics Health Inc
4.31 224.40M 0 0 0 0.00
Pharmaceutical Retailers icon
WBA
Walgreens Boots Alliance Inc
11.14 9.66B 147.66B -8.64B -363.00M -10.01
Pharmaceutical Retailers icon
HITI
High Tide Inc
1.975 152.97M 376.07M -22.41M 18.73M -0.298
Pharmaceutical Retailers icon
PETS
Petmed Express Inc
4.08 86.55M 270.52M -6.08M 17.42M -0.2944
Pharmaceutical Retailers icon
SCNX
Scienture Holdings Inc
1.4469 12.95M 0 0 0 0.00

Wellgistics Health Inc Aktie (WGRX) Neueste Nachrichten

pulisher
Mar 27, 2025

Wellgistics Health Expands with AI and Public Transition - TipRanks

Mar 27, 2025
pulisher
Mar 27, 2025

Wellgistics Health shares annual letter to shareholders - TipRanks

Mar 27, 2025
pulisher
Mar 27, 2025

Wellgistics Health Annual Letter to Shareholders From the Office of the CEO March 2025 - The Manila Times

Mar 27, 2025
pulisher
Mar 24, 2025

Why Retail Traders Are Rushing Into Small-Cap Wellgistics Health Weeks After Its Nasdaq Debut - Asianet Newsable

Mar 24, 2025
pulisher
Mar 21, 2025

Wellgistics Health Achieves SOC 2 Type 1 Compliance - TipRanks

Mar 21, 2025
pulisher
Mar 20, 2025

12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga

Mar 20, 2025
pulisher
Mar 20, 2025

Wellgistics Health, Inc. Rings the Opening Bell - Nasdaq

Mar 20, 2025
pulisher
Mar 20, 2025

Wellgistics Health, Inc. Rings the Nasdaq Stock Market Opening Bell - Nasdaq

Mar 20, 2025
pulisher
Mar 18, 2025

Wellgistics Health Achieves SOC 2 Type 1 Compliance, Enhancing Security For Pharmacy Solutions - Nasdaq

Mar 18, 2025
pulisher
Mar 18, 2025

Wellgistics Health achieves SOC 2 Type 1 compliance - TipRanks

Mar 18, 2025
pulisher
Mar 18, 2025

Wellgistics Health Achieves SOC 2 Type 1 Compliance, Enhancing Commitment to Data Security and Regulatory Standards - Nasdaq

Mar 18, 2025
pulisher
Mar 18, 2025

Wellgistics Health Achieves SOC 2 Type 1 Compliance, Strengthening Security for AI-Driven Pharmacy Solutions and Employer-Based Healthcare Models - The Manila Times

Mar 18, 2025
pulisher
Mar 06, 2025

Form 424B3 Wellgistics Health, Inc. - StreetInsider.com

Mar 06, 2025
pulisher
Mar 06, 2025

Wellgistics Health announces departure of CEO Tim Canning - MSN

Mar 06, 2025
pulisher
Mar 05, 2025

$68M Tampa health tech firm appoints new CEO - Business Observer

Mar 05, 2025
pulisher
Mar 05, 2025

Wellgistics Health Appoints Brian Norton to Succeed Tim Canning as CEO -March 05, 2025 at 04:40 am EST - Marketscreener.com

Mar 05, 2025
pulisher
Mar 04, 2025

Wellgistics Health Appoints Brian Norton CEO - citybiz

Mar 04, 2025
pulisher
Mar 04, 2025

Wellgistics Health, Inc. Announces Leadership Transition: Brian Norton Appointed as CEO Following Tim Canning's Departure - The Manila Times

Mar 04, 2025
pulisher
Mar 04, 2025

Wellgistics Health appoints Brian Norton as CEO - TipRanks

Mar 04, 2025
pulisher
Mar 04, 2025

Wellgistics Health, Inc. Announces Leadership Transition: Brian Norton Appointed as CEO Following Tim Canning’s Departure - TradingView

Mar 04, 2025
pulisher
Mar 04, 2025

Wellgistics Health, Inc. Announces Leadership Transition: Brian Norton Appointed as CEO Following Tim - EIN News

Mar 04, 2025
pulisher
Mar 04, 2025

Wellgistics Health Partners With Protega Pharmaceuticals To Expand Education And Access To ROXYBOND - Nasdaq

Mar 04, 2025
pulisher
Mar 04, 2025

Wellgistics partners with Protega to distribute opioid alternative By Investing.com - Investing.com Australia

Mar 04, 2025
pulisher
Mar 04, 2025

Protega Pharmaceuticals Collaborates With Wellgistics To Support Pharmacist Education - Marketscreener.com

Mar 04, 2025
pulisher
Mar 04, 2025

Wellgistics partners with Protega to distribute opioid alternative - Investing.com India

Mar 04, 2025
pulisher
Mar 04, 2025

Protega Pharmaceuticals collaborates with Wellgistics to support pharmacist education and increase patient access to the first and only FDA-approved abuse-deterrent immediate-release opioid, ROXYBOND™ - The Manila Times

Mar 04, 2025
pulisher
Mar 04, 2025

Wellgistics Health, Inc. and Protega Pharmaceuticals Collaborate to Enhance Access and Education for ROXYBOND™ Pain Management - Nasdaq

Mar 04, 2025
pulisher
Mar 04, 2025

Protega collaborates with Wellgistics for Roxybond launch - The Pharma Letter

Mar 04, 2025
pulisher
Mar 03, 2025

Protega Pharmaceuticals collaborates with Wellgistics Health to support pharmacist education and increase patient access to the first and only FDA-approved abuse-deterrent immediate-release opioid, ROXYBOND™ - PR Newswire

Mar 03, 2025
pulisher
Feb 28, 2025

Wellgistics Health Expands with Tollo Health Partnership - TipRanks

Feb 28, 2025
pulisher
Feb 26, 2025

Wellgistics Health (NASDAQ:WGRX) Gaining First Mover Advantage in Untapped GLP-1 and Long Covid Markets - Insider Financial

Feb 26, 2025
pulisher
Feb 26, 2025

Wellgistics Expands Partnership With Tollo Health To Market Medical Foods For GLP-1, Long COVID - Nasdaq

Feb 26, 2025
pulisher
Feb 26, 2025

Wellgistics Expands Healthcare Ecosystem with Tollo Health Agreement, Targeting Multi-Billion Dollar GLP-1 and Long COVID Market - The Manila Times

Feb 26, 2025
pulisher
Feb 25, 2025

D. Boral Capital Served as Joint Bookrunner to Wellgistics Health, Inc. (Nasdaq: WGRX) in connection with its $4.0 Million Initial Public Offering - Bellingham Herald

Feb 25, 2025
pulisher
Feb 24, 2025

Wellgistics Health, Inc. Announces Closing of $4.0 Million Initial Public Offering - Yahoo Finance

Feb 24, 2025
pulisher
Feb 22, 2025

Wellgistics Health (NASDAQ:WGRX) IPO: Revolutionizing Pharmacy Care for a Patient-Centric Future - Insider Financial

Feb 22, 2025
pulisher
Feb 21, 2025

Wellgistics Health Announces Pricing Of $4.0 Million Initial Public Offering -February 21, 2025 at 09:07 am EST - Marketscreener.com

Feb 21, 2025
pulisher
Feb 21, 2025

Wellgistics Health Prices $4 Million IPO - MarketScreener

Feb 21, 2025
pulisher
Feb 20, 2025

Preview: Danam Health, Inc Set To IPO Tomorrow - Benzinga

Feb 20, 2025
pulisher
Feb 19, 2025

IPO Roundup: Anbio Biotechnology, Wellgistics Health and more - MSN

Feb 19, 2025
pulisher
Feb 18, 2025

IPO Roundup: Anbio Biotechnology, Wellgistics Health and more (IPO:NYSEARCA) - Seeking Alpha

Feb 18, 2025
pulisher
Feb 12, 2025

Wellgistics Health Plans $4 Million IPO for February 20th (WGRX) - The AM Reporter

Feb 12, 2025
pulisher
Feb 07, 2025

Wellgistics Named Diamond Sponsor of Leigh Steinberg's 37th Annual Super Bowl Party - openPR.com

Feb 07, 2025
pulisher
Feb 04, 2025

Wellgistics Health (WGRX) Plans to Raise $4 Million in February 20th IPO - Defense World

Feb 04, 2025
pulisher
Feb 03, 2025

Upcoming IPOs This Week (February 3 to February 7) – Get Ready to Invest - TipRanks

Feb 03, 2025
pulisher
Dec 11, 2024

Wellgistics Health Pursues Micro-IPO Plan (Pending:WGRX) - Seeking Alpha

Dec 11, 2024
pulisher
Dec 06, 2024

WGRX IPO NewsPharmaceutical wholesaler Wellgistics Health sets terms for $4.5 million IPO - renaissancecapital.com

Dec 06, 2024
pulisher
Jul 25, 2024

Tampa pharma company stacked with former McKesson execs launches IPO - The Business Journals

Jul 25, 2024
pulisher
Sep 14, 2021

Wellgistics Signs Exclusive Distribution Agreement With Signal Relief - Business Wire

Sep 14, 2021

Finanzdaten der Wellgistics Health Inc-Aktie (WGRX)

Es liegen keine Finanzdaten für Wellgistics Health Inc (WGRX) vor. Überprüfen Sie andere Aktien für weitere Informationen.

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$1.88
price down icon 0.26%
$4.12
price down icon 0.36%
$1.43
price down icon 0.09%
pharmaceutical_retailers SSY
$1.00
price down icon 1.95%
$0.9612
price down icon 3.81%
Kapitalisierung:     |  Volumen (24h):